•Warner Bros. Discovery lawyers briefed executives on the risks of an antitrust lawsuit by state attorneys general to block the merger with Paramount Skydance.
•Scienture Holdings announced a strategic shift from a digital pharmacy marketplace to a specialty pharmaceutical company focusing on CNS and cardiovascular diseases.
•The company reported a net loss of $4.4 million for the six months ending June 30, 2024, and faces substantial doubt about its ability to continue as a going concern.
•The company may receive up to $50 million via an ELOC Purchase Agreement to fund R&D, regulatory approvals, and debt repayment.